GRUND NICHOLAS (Chief Commercial Officer) sold 13.1% of their position (84.83K shares) of AKEBIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $117.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/4/2026ACC: 0001661887-26-000002
Officer· Chief Commercial Officer
Since Feb 2026
-84.83K
Net shares
Net seller
$117.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
84.83K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−53.59K
Price / share
$1.39
Trade value
$74.48K
% of position
8.3%
2/2/2026
646.58K→592.99K
Common Stock
Direct
Shares
−31.24K
Price / share
$1.39
Trade value
$43.43K
% of position
5.3%
2/2/2026
592.99K→561.75K
Total
Net shares
−84.83K
Net value
-$117.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −53.59K | $1.39 | $74.48K | 8.3% | 646.58K | 592.99K |
| Common Stock Direct | 2/2/2026 | S · Sale | −31.24K | $1.39 | $43.43K | 5.3% | 592.99K | 561.75K |
| Total | −84.83K | -$117.91K | ||||||
Derivative Transactions0
No derivative transactions reported